BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 15526164)

  • 21. Sites of retroviral DNA integration: From basic research to clinical applications.
    Serrao E; Engelman AN
    Crit Rev Biochem Mol Biol; 2016; 51(1):26-42. PubMed ID: 26508664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.
    Mitchell RS; Beitzel BF; Schroder AR; Shinn P; Chen H; Berry CC; Ecker JR; Bushman FD
    PLoS Biol; 2004 Aug; 2(8):E234. PubMed ID: 15314653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro murine leukemia retroviral integration and structure fluctuation of target DNA.
    Tsuruyama T; Liu W; Yoshikawa K
    PLoS One; 2012; 7(2):e31533. PubMed ID: 22348097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weak palindromic consensus sequences are a common feature found at the integration target sites of many retroviruses.
    Wu X; Li Y; Crise B; Burgess SM; Munroe DJ
    J Virol; 2005 Apr; 79(8):5211-4. PubMed ID: 15795304
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insertion of retroviral vectors in NOD/SCID repopulating human peripheral blood progenitor cells occurs preferentially in the vicinity of transcription start regions and in introns.
    Laufs S; Nagy KZ; Giordano FA; Hotz-Wagenblatt A; Zeller WJ; Fruehauf S
    Mol Ther; 2004 Nov; 10(5):874-81. PubMed ID: 15509505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-wide analysis of retroviral DNA integration.
    Bushman F; Lewinski M; Ciuffi A; Barr S; Leipzig J; Hannenhalli S; Hoffmann C
    Nat Rev Microbiol; 2005 Nov; 3(11):848-58. PubMed ID: 16175173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of retroviral vectors for gene therapy-what are the risks? A review of retroviral pathogenesis and its relevance to retroviral vector-mediated gene delivery.
    Anson DS
    Genet Vaccines Ther; 2004 Aug; 2(1):9. PubMed ID: 15310406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early steps of retrovirus replicative cycle.
    Nisole S; Saïb A
    Retrovirology; 2004 May; 1():9. PubMed ID: 15169567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retroviral infection of hES cells produces random-like integration patterns.
    Lim KI
    Mol Cells; 2012 May; 33(5):525-31. PubMed ID: 22526396
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nucleotide sequence analysis of avian retroviruses: structural similarities with transposable elements.
    Ju G; Hishinuma F; Skalka AM
    Fed Proc; 1982 Aug; 41(10):2659-61. PubMed ID: 6286367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.
    Recchia A; Perani L; Sartori D; Olgiati C; Mavilio F
    Mol Ther; 2004 Oct; 10(4):660-70. PubMed ID: 15451450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retroviral protein transfer: falling apart to make an impact.
    Maetzig T; Baum C; Schambach A
    Curr Gene Ther; 2012 Oct; 12(5):389-409. PubMed ID: 22934617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanisms governing lentivirus integration site selection.
    Ciuffi A
    Curr Gene Ther; 2008 Dec; 8(6):419-29. PubMed ID: 19075625
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lack of site-specific integration of the recombinant adeno-associated virus 2 genomes in human cells.
    Ponnazhagan S; Erikson D; Kearns WG; Zhou SZ; Nahreini P; Wang XS; Srivastava A
    Hum Gene Ther; 1997 Feb; 8(3):275-84. PubMed ID: 9048194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cells.
    Hematti P; Hong BK; Ferguson C; Adler R; Hanawa H; Sellers S; Holt IE; Eckfeldt CE; Sharma Y; Schmidt M; von Kalle C; Persons DA; Billings EM; Verfaillie CM; Nienhuis AW; Wolfsberg TG; Dunbar CE; Calmels B
    PLoS Biol; 2004 Dec; 2(12):e423. PubMed ID: 15550989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interactions between Retroviruses and the Host Cell Genome.
    Poletti V; Mavilio F
    Mol Ther Methods Clin Dev; 2018 Mar; 8():31-41. PubMed ID: 29159201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Basis of HTLV type 1 target site selection.
    Leclercq I; Mortreux F; Gabet AS; Jonsson CB; Wattel E
    AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1653-9. PubMed ID: 11080806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retroviral integration profiles: their determinants and implications for gene therapy.
    Lim KI
    BMB Rep; 2012 Apr; 45(4):207-12. PubMed ID: 22531129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotoxicity of retroviral integration in hematopoietic cells.
    Nienhuis AW; Dunbar CE; Sorrentino BP
    Mol Ther; 2006 Jun; 13(6):1031-49. PubMed ID: 16624621
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudotyped Viruses for Retroviruses.
    Solomon M; Liang C
    Adv Exp Med Biol; 2023; 1407():61-84. PubMed ID: 36920692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.